INR 584.1
(1.64%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 3.15 Billion INR | -16.03% |
2022 | 3.76 Billion INR | -2.23% |
2021 | 3.84 Billion INR | 20.11% |
2020 | 3.2 Billion INR | -2.25% |
2019 | 3.27 Billion INR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 1.18 Billion INR | 39.41% |
2024 Q1 | 708.22 Million INR | -6.96% |
2023 Q2 | 832.52 Million INR | -15.46% |
2023 Q3 | 959.09 Million INR | 15.2% |
2023 Q1 | 984.8 Million INR | -8.94% |
2023 Q4 | 761.23 Million INR | -20.63% |
2023 FY | 3.15 Billion INR | -16.03% |
2022 Q2 | 825.46 Million INR | 10.11% |
2022 FY | 3.76 Billion INR | -2.23% |
2022 Q4 | 1.08 Billion INR | 16.33% |
2022 Q3 | 929.67 Million INR | 12.62% |
2022 Q1 | 749.64 Million INR | 0.0% |
2021 FY | 3.84 Billion INR | 20.11% |
2020 FY | 3.2 Billion INR | -2.25% |
2019 FY | 3.27 Billion INR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Alfavision Overseas (India) Limited | 10.46 Million INR | -30099.885% |
Biocon Limited | 91.73 Billion INR | 96.556% |
Concord Biotech Limited | 6.11 Billion INR | 48.303% |
Dishman Carbogen Amcis Limited | 4.9 Billion INR | 35.576% |
FERMENTA BIOTECH LIMITED | 1.82 Billion INR | -73.378% |
GENOMIC VALLEY BIOTECH LIMITED | 1.65 Million INR | -191280.282% |
Lyka Labs Limited | 145.95 Million INR | -2064.554% |
Panacea Biotec Limited | 1.35 Billion INR | -133.102% |
SAMSRITA LABS LIMITED | -1.28 Million INR | 246322.731% |
Servoteach Industries Limited | - INR | -Infinity% |
SMS Lifesciences India Limited | 329.57 Million INR | -858.568% |
Supriya Lifescience Limited | 2.65 Billion INR | -19.135% |
Syngene International Limited | 12.43 Billion INR | 74.6% |
TAKE Solutions Limited | 183.42 Million INR | -1622.391% |
Titan Biotech Limited | 884.66 Million INR | -257.11% |
Transgene Biotek Limited | -1.69 Million INR | 186814.539% |
Vanta Bioscience Limited | 7.12 Million INR | -44270.927% |